Convatec Group PLC said Paul Moraviec will retire as CEO and will no longer be a board member, effective immediately.

The U.K.-based company appointed its nonexecutive director Rick Anderson, former group chairman of Johnson & Johnson, as interim CEO with immediate effect. Anderson will cease to be a member of the audit and risk committee, effective immediately.

The company said Moraviec will be available to ensure an orderly transition.

Convatec develops and markets medical products and technologies and is focused on therapies for managing chronic conditions, including wound care and ostomy care.